Financials
Income statement
Fiscal date | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
---|---|---|---|---|
Total reported revenue | 49.8B | 51.4B | 50.0B | 48.4B |
Cost of revenue | 22.4B | 22.2B | 23.4B | 21.0B |
Gross profit | 27.4B | 29.3B | 26.6B | 27.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 5.5B | 6.3B | 3.1B | 5.2B |
Non operating interest income | ||||
Income | 1M | 0 | 1M | 0 |
Expense | 27M | 24M | 23M | 21M |
Other income expense | — | — | — | — |
Pretax income | 5.4B | 6.3B | 2.8B | 5.3B |
Tax provision | 1.9B | 2.1B | 344M | 1.9B |
Net income | 3.5B | 4.2B | 2.5B | 3.4B |
Basic EPS | — | 48.4 | — | — |
Diluted EPS | — | 48.4 | — | — |
Basic average shares | — | 86.8M | — | — |
Diluted average shares | — | 86.8M | — | — |
EBITDA | 5.6B | 6.4B | 3.1B | 5.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |